Tumor endothelial cells (TECs) are generally different from their normal counterparts due to different gene expression [10,11] The chemokine receptor CXCR7 is upregulated in TECs and therefore constitutes a novel marker [12]. This evidence concerns the gene ACKR3 and neoplasm.